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Differential expression and induction of mRNAs encoding two inducible
nitric oxide synthases in rat kidney. We used quantitative PCR methods
and renal microdissection to characterize the expression of inducible nitric
oxide synthase (iNOS) mRNAs in rat kidney and cultured glomerular
mesangial cells. A partial cDNA homologous to murine macrophage
iNOS (macNOS), but distinct from rat vascular smooth muscle iNOS
(vsmNOS), was cloned from normal rat kidney. macNOS was the principal
iNOS isoform tonically expressed in microdissected glomeruli, proximal
tubules, medullary thick ascending limbs (mTAL), cortical and inner
medullary collecting ducts (IMCD), and cultured mesangial cells, whereas
vsmNOS was the major isoform expressed in arcuate and interlobular
arteries. Basal macNOS expression was greatest in mTALs and IMCDs.
Restriction mapping of RT-PCR products indicated that basal expression
of macNOS mRNA was comparable to that of vsmNOS in cortex, but
greater than vsmNOS in outer and inner medulla. However, compared to
controls, lipopolysaccharide (LPS)-treated rats exhibited a much greater
proportion of vsmNOS mRNA and higher levels of total iNOS mRNA in
each zone. Similarly, TNFa and IF-y preferentially induced expression of
vsmNOS mRNA in cultured mesangial cells. We conclude that two 1NOS
isoforms are constitutively and heterogeneously expressed in the normal
rat kidney, and that endotoxemia and cytokines differentially induce their
expression.
Nitric oxide (NO), a labile radical gas, is an important intercel-
lular messenger that plays a prominent role in a host of physio-
logical and pathophysiological processes [reviewed in 1 and 2].
Recent evidence indicates that NO has potent effects on renal
function, including modulation of renal and glomerular hemody-
namics, renin secretion, the tubuloglomerular feedback response,
and sodium excretion [reviewed in 3]. NO production is mediated
by the activity of NO synthase (NOS), a family of at least three
isoenzymes that synthesizes NO from a terminal guanidino nitro-
gen of L-arginine. NOS Types I (neuronal, [4])and III (endothe-
hal, [5]) are constitutively expressed, but quiescent until activated
by increased Ca2 levels that sustain calmodulin binding [1]. In
contrast, Type II, or "inducible" NOS (iNOS) is strongly ex-
pressed after transcriptional activation by cytokines or lipopoly-
saccharide (LPS) [6], the major component of bacterial endotoxin.
This form of the enzyme remains active for sustained periods and
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generally does not require increased Ca2 levels for activation.
iNOS mediates many of the cytotoxic actions of activated macro-
phages and appears to play an important role in the hypotension
and organ failure associated with endotoxemia in both animal
models and humans [2, 7].
Recent molecular cloning and cell expression studies charac-
terized cDNAs encoding iNOS from murine macrophages (m-
macNOS, [6]), cytokine-induced rat (r-hepNOS, [8]) and human
hepatocytes [9], uninduced human articular chondrocytes [10],
and cytokine-induced vascular smooth muscle cells of the rat
(r-vsmNOS, [11]). The r-hepNOS and r-vsmNOS cDNAs were
99% identical in their nucleotide sequences, and they shared 93%
and 80% amino acid sequence identity with m-macNOS and the
two human iNOS clones, respectively. It was not established,
however, whether the structural diversity of rat iNOS's repre-
sented simply species differences in a homologous gene, allelic
variation, or a family of iNOS genes. However, the fact that the
Ca2!calmodulin-dependence of iNOS activity isolated from dif-
ferent tissues varied significantly [9, 10, 12, 13], suggested that
structurally and functionally unique isoenzymes of INOS may be
expressed in some cell types.
Despite growing evidence suggesting important roles for NO in
renal function, relatively little is known about the expression of
iNOS along the nephron. Although, to date, no study of iNOS
mRNA distribution in the kidney in vivo has been reported,
macNOS transcripts have been identified in primary cultures of
proximal tubule cells and inner medullary collecting duct (IMCD)
cells [14] of the rat, and immunologically-inducible NO produc-
tion has been documented in cultured glomerular mesangial cells
[15, 16]. Most recently, Tojo et a! [17] found that a polyclonal
antibody to an induced form of NOS from vascular smooth muscle
cells immunolabeled the terminal afferent arteriole and thick
ascending limb of Henle of the normal rat kidney, but not
glomerular mesangial cells (even after LPS treatment of the
animals). Moreover, preliminary studies using another iNOS
antibody demonstrated immunoreactivity in intercalated cells of
the cortical collecting duct (CCD) of the normal rat [18]. In these
two immunohistochemical studies, the apparent basal expression
of an "inducible" NOS and the absence of iNOS immunolabeling
in mesangial cells raised the possibility that multiple molecular
forms of iNOS are expressed in the rat kidney and that iNOS may
be constitutively expressed in specific renal cell types.
Since knowledge of the specific NOS isoforms expressed in the
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kidney and their segmental distribution is central to the study of
the regulation of intrarenal NO production, the present studies
were designed to determine the molecular identities, microlocal-
ization, and relative abundance of the iNOS mRNAs in the
normal rat kidney. We used nephron microdissection combined
with competitive reverse transcription-PCR (RT-PCR) to com-
pare the relative iNOS transcript abundance along the nephron
under basal conditions. We also developed an RT-PCR assay that
employed a single pair of primers and exploited diagnostic
restriction cleavage patterns of the amplified iNOS products. This
strategy allowed us to compare the relative amounts of iNOS
mRNAs in the kidney under basal and LPS-induced conditions in
vivo, and the response of cultured glomerular mesangial cells to
cytokine treatment. Our results indicate the expression of two
distinct iNOS mRNAs in the normal rat kidney and cultured
mesangial cells, and demonstrate that they are differentially
distributed in the renal parenchyma and respond differentially to
LPS or cytokine induction.
Methods
Cell culture
Glomerular mesangial cells harvested from male Sprague-
Dawley rats (150 to 200 g body wt) were provided by Dr. Nicolas
Guzman (University of Florida), and were prepared as previously
described [19]. Clonal populations (dilute-plated and further
expanded) of these cells were grown in DMEM containing 10%
FBS, 100U/mI penicillin, 100 tg/ml streptomycin, 5 jig/mI insulin,
5 gg/ml transferrin, and 5 ng/ml selenium (complete medium),
and they were studied in passages 10-14. For induction of iNOS
gene expression, paired plates of confluent mesangial cells were
treated with either complete medium or complete medium sup-
plemented with 150 U/ml murine, recombinant TNFa and 500
U/mI rat, recombinant interferon (IF)-'y (both from GIBCO
BRL) for seven hours at 37°C.
Kidney macrodissection and microdissection
Male Sprague-Dawley rats weighing 150 to 200 g were allowed
free access to standard rat chow (Ralston-Purina #5001; sodium
content 0.3 g/100 g) and tap water. The procedures for macrodis-
section of cortex, outer medulla, and inner medulla, and micro-
dissection of renal segments were conducted exactly as previously
reported [201, with the following additional details. After collage-
nase perfusion and excision, the kidneys were cut into coronal
slices and incubated at 37°C in Buffer A containing 1.5 mg/mI
collagenase but only 0.19 mg/mI Pronase for 20 to 25 minutes for
IMCDs, or 30 to 40 minutes for glomeruli, proximal convoluted
tubules (PCT), proximal straight tubules (PST), medullary TAL
(mTAL), cortical collecting ducts (CCD), and arcuate and inter-
lobular arteries. Following dissection and washing, 4 to 6 tubules
(each —2 mm in length), 4 to 6 vessels (each —4 to 6 mm in
length), or 8 to 10 glomeruli were transferred directly into a
microcentrifuge tube, flash frozen in a dry ice/ethanol bath, and
stored at —80°C until the time of RNA isolation. The arcuate and
interlobular arteries were pooled as a single sample. As a control
for possible carry-over contamination, 10 j.d of the dissection
medium were collected and carried through the RNA isolation,
RT, and PCR steps in parallel with the tissue samples. In contrast
to other investigators [211, we did not include RNAse inhibitors in
the perfusion or dissection solutions. Thus it is possible that some
mRNA degradation occurred during the tissue preparation.
Oligonucleotides used for amplification
The primers used for amplification of (3-actin cDNA were forward,
5 '-TCGAAflCI'GGAGAAGAGCFATGAGCTGCCG-3' nude-
otides 2498-2522, exon 4, [22] and reverse, 5'-TCGGATCCGT-
GCCACCAGACAGCACTGTGflG-3' (nucleotides 2765-2788,
exon 5). Amplification of 13-actin eDNA yielded a 217 bp product,
whereas amplification of genomic DNA would produce a 304 bp
product. For amplification of iNOS, the sense primer iNOS1 was
identical to nucleotides 1948-1971 of m-macNOS [61, and it
contained only two, separated nucleotide mismatches when com-
pared to the corresponding regions of the r-hepNOS [8] and
r-vsmNOS [11] sequences. The antisense primer iNOS2 was
identical to nucleotides 2147-2170 of the m-macNOS sequence,
and it contained a single nucleotide difference with respect to the
corresponding regions of the other two iNOS isoforms. The iNOS
primers were selected for several reasons. First, they were de-
signed to anneal with virtually equal efficiency to the r-hepNOS,
r-vsmNOS, and the m-macNOS, so that PCR amplification would
be expected to detect all three iNOS mRNAs. Second, these
primers framed a region of sequence diversity among the iNOS
isoforms (Results and Figure 2A), thus permitting the use of
restriction mapping and nucleotide sequence analysis to defini-
tively distinguish the specific NOS isoform(s) amplified in the
PCR. Third, they spanned a gap (compared to the brain [4] and
endothelial [5] NOS isoforms) in the coding sequence between
the Ca27caImodulin binding site and the FMN site, so that
spurious amplification of the brain or endothelial NOS isoforms
would result in a larger (---360 bp) product. Finally, iNOS primers
nearly identical to these had been used successfully in studies of
cultured renal cells [14].
Isolation of total RNA and RT-PCR
Total cytoplasmic RNA was extracted from the macro- or
microdissected tissues or from the cultured cells using a commer-
cially available kit, RNAZOL II (TEL-TEST "B", Inc.). The final
RNA pellets from cortex, outer and inner medulla or the cultured
cells were resuspended in 20 to 100 1d of diethylpyrocarbonate
(DEPC)-treated water. The RNA pellets isolated from the gb-
meruli and tubules were resuspended in DEPC-treated water such
that 5 jd of RNA corresponded to 1 mm tubule or 2 glomeruli.
First strand eDNA was synthesized from 1 jig of total RNA
harvested from each of the three macrodissected zones or cul-
tured cells, or from 5 ,td of the microdissection RNA sample, using
oligo-(dT)17 primer and murine Moloney leukemia virus RT
(GIBCO BRL). PCRs were performed in a Perkin Elmer 4800
Thermal Cycler (Perkin Elmer-Cetus) on an aliquot of the cDNA
with the components of the GeneAmp Kit (Perkin Elmer-Cetus)
and 1 to 2 jiM of each primer in a final volume of 50 gl. After an
initial melt at 95°C for two minutes, 40 cycles (iNOS) or 25 cycles
(f3-actin) of amplification (95°C X 1 mm, 65°C X 1 mm, and 72°C
x 1 mm) were performed, followed by a final extension at 72°C x
7 mm. Meticulous care was taken to prevent contamination of
samples, reagents, and primers. The PCR core reagents were
dispensed in a dedicated laminar flow hood in a room separated
from the main laboratory, and the cDNA samples and primers
were dispensed in another laminar flow hood in a different room.
Dedicated pipetmen and plugged pipet tips were used for all
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experiments. Several control experiments were performed: (a)
RNA from each parenchymal zone or from the microdissected
structures was directly amplified, without RT, to determine
whether contaminating cDNA or genomic DNA had been copu-
rifled with the RNA; (b) negative controls for the RT step (no
added RNA) and the PCR (no added cDNA) were performed to
control for contamination of the RT and PCR components; and
(c) as noted earlier, an aliquot of the dissection medium for each
tissue sample was amplified.
To verify the authenticity of the PCR products, the amplified
iNOS DNAs were initially precipitated in ethanol and sequenced
directly with the AmpliTaq Cycle Sequencing Kit (Perkin Elmer
Cetus). In subsequent experiments, the PCR products were
extracted with phenol/chloroform, ethanol precipitated, and di-
gested with Aci! or Sty!, since these enzymes would be expected to
produce distinctive patterns of restriction fragments for each
isoform (Results). Sty! cleaves r-macNOS into 139 bp, 58 bp, and
26 bp fragments, whereas it digests r-vsmNOS and r-hepNOS into
197 bp and 26 bp fragments. AciI does not cleave r-macNOS, but
digests r-vsmNOS into 154 bp and 69 bp fragments, and r-
hepNOS into 108 bp, 69 bp, and 46 bp fragments. The restriction
products were analyzed on 2.5% agarose gels containing 0.5 jg/ml
ethidium bromide in Tris borate/EDTA buffer. To provide a
rough estimate of the relative proportions of r-macNOS to
r-vsmNOS mRNA in the three parenchymal zones, the amount of
[a-32P]-dCTP incorporated during amplification into the 139 bp
Sty! (r-macNOS) and 154 bp Aci! (r-vsmNOS) cleavage product
bands was measured by liquid scintillation counting. For cloning
of the r-macNOS PCR product, the amplified products from
cortex were excised from the gel, and the DNA purified using the
PREP-A-GENE kit (B!O-RAD). The purified PCR products
were then subcloned into pBluescript KS (Stratagene) and trans-
formed into DH5a competent cells (GIBCO-BRL). The recom-
binant plasmids were purified by the alkaline lysis method and
used as double-stranded templates for sequencing with Sequenase
(U.S. Biochemical Corp.). Both DNA strands from five indepen-
dent PCRs obtained from five different animals were sequenced
and compared to detect any nucleotide misincorporation errors
that might have occurred during amplification.
Construction of LXr-macNOS competitor template and
competitive PCR
Relative quantitation of iNOS eDNA in the microdissected
structures was performed by a modification of the method of
Peten et al [21], using a tenfold dilution series (101 to iO
copies/j.d) of an r-macNOS cDNA mutant to serve as an internal
control. The mutant r-macNOS template was constructed by
excision of a 139 bp Sty!-Sty! fragment from the 223 bp r-macNOS
fragment cloned in pBluescript (Results), followed by re-ligation
of the ends. This deletion mutant (&-macNOS) retained the same
primer template sequences as the wild-type r-macNOS eDNA,
and was shown to be amplified with virtually equal efficiency.
Equal amounts of sample cDNA were aliquoted into separate
tubes containing the dilutions of &-macNOS, and PCR was
performed as described above, except that 0.4 Ci [a-32P]dCTP
was included in the reaction mix. Bands corresponding to both
wild-type iNOS and &-macNOS were excised from the gel and
counted for f3 emissions. Background counts were subtracted, and
the cpm for each sample were normalized for product size. The
average of three determinations from each unknown sample and
the samples from the competitor dilution series were compared.
The data were graphed as a log:log plot, and a regression line was
calculated. The relative amount of iNOS eDNA was determined
by calculating the amount of &-macNOS DNA needed to pro-
duce equal molar amounts of target and competitor products. The
data are presented as the approximate number of eDNA mole-
cules per mm tubule length, or per glomerulus, and represent the
mean relative cDNA level for the pooled structures.
LPS and cytokine induction experiments
For studies of the effects of LPS on iNOS gene expression, rats
were injected i.p. with vehicle or 4 mg/kg body wt LPS (derived
from Escherichia coli serotype 026:B6; Sigma) 16 hours and four
hours before sacrifice. RNA was harvested from the cortex, outer
and inner medulla, and reverse transcribed. As a relative control
for RNA recovery and eDNA synthesis, and to determine whether
an observed change in mRNA abundance was iNOS gene-specific
(rather than a generalized alteration), 13-actin eDNA was ampli-
fied in the presence of 0.4 pCi [a-32P]dCTP in parallel with iNOS
cDNAs for each sample. 13-actin mRNA is known to be expressed
in relatively comparable amounts throughout the rat kidney [23].
The j3-actin and iNOS bands were excised from the gels, and their
incorporated cpms measured. The amount (in cpm) of iNOS PCR
product was then normalized for the radioactivity incorporated
into the amplified 13-actin cDNA.
Statistical analysis
When indicated, the data are presented as mean SEM,
Differences between groups were compared by unpaired t-test
when appropriate. Differences were considered significant for P <
0.05. Regression lines were calculated by linear or logarithmic
regression analysis, as appropriate.
Results
Detection and analysis of iNOS mRNAs in renal
parenchymal zones
To determine the iNOS isoforms expressed in the major
parenchymal zones of the normal, uninduced rat kidney, we
combined RT-PCR of macrodissected renal tissue with DNA
sequencing of the resultant products. cDNAs derived from cortex,
outer and inner medulla were used in PCRs with the iNOS1 and
iNOS2 primers. As seen in Figure 1, a single 223 bp band of
predicted size was amplified from each of the parenchynial zones.
Amplification of the RNA directly, without RT, from each zone
produced no detectable product on the ethidium bromide-stained
gels, confirming that the observed products were indeed amplified
from the target eDNA, and not from genomic DNA. Moreover,
PCR using the common master mix of reagents and primers in the
absence of template yielded no detectable product.
Direct DNA sequence analysis of the cortex PCR products
identified two structurally distinct iNOS cDNAs: one identical in
sequence to the corresponding region of r-vsmNOS, and the other
(r-macNOS) virtually identical in structure to m-macNOS (Fig. 2).
The r-macNOS eDNA differed from the corresponding region of
m-macNOS at only two of 175 positions in the nucleotide
sequence, which resulted in a single nonconservative amino acid
substitution (arginine607 of the m-macNOS was substituted with
asparagine in r-macNOS). Identical findings were obtained for
CTX OM IM NT
RT (+) (—) (+) (-4 (+) (—) (+)
223bp
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Fig. 1. RT-PCR detection of iNOS mRftJAs in
rat kidney. Ethidium bromide-stained 2.5%
agarose gel of iNOS PCR products amplified
from first strand cDNAs (RT+) or RNAs
(RT—) from cortex (CTX), outer medulla
(OM), and inner medulla (IM) of a normal rat.
NT (no template) indicates PCR using the
common master mix of primers and reagents
used to ampli4' products from each zone, in the
absence of template DNA or RNA. Molecular
weight standards were the 1 kb ladder from
GIBCO-BRL. These results are representative
of four experiments.
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Fig. 2. Stnictural diversity of iNOS cDNAs. Comparison of nucleotide (A) and deduced amino acid (B) sequences of the r-macNOS and r-vsmNOS PCR
products with other known iNOS isoforms. Dashes (-) indicate sequence identity with the r-macNOS sequence, and capital letters represent nucleotide
or amino acid substitutions. Primer sequences at both ends of r-macNOS and r-vsmNOS have been deleted. Numbers represent positions in published
eDNA and deduced amino acid sequences 6, 8—il]. h-ehonNOS: human chondrocyte iNOS; other abbreviations are as in text.
r-macNOS clones obtained in independent PCRs from five dif-
ferent rats and sequenced by both our laboratory and the DNA
Sequencing Core Facility of the University of Florida College of
Medicine. The nucleotide sequence of the r-macNOS eDNA was
91% and 92% identical to that of the corresponding regions of
r-vsmNOS, and r-hepNOS, respectively (Fig. 2A). At the amino
acid level, r-macNOS shared 93%, 93%, and 84% sequence
identity with the corresponding regions of r-hepNOS, r-vsmNOS,
and the two human iNOS clones, respectively (Fig. 2B).
To determine whether both iNOS isoforms are expressed in
each parenchymal zone, we subjected the RT-PCR products to
restriction cleavage analysis with StyI and AciI (Fig. 3A). Cleavage
products indicative of both r-macNOS and r-vsmNOS were iden-
tified in each parenehymal zone of every rat studied (Fig. 3B).
Complete digestion of the PCR products amplified from cortex,
outer and inner medulla of the normal rat with StyL yielded a 197
bp (indicative of r-vsmNOS or r-hepNOS) and a 139 bp fragment
(characteristic of r-macNOS) in each region. AciI treatment of the
PCR products (Fig. 3B) from the three parenchymal zones
produced principally the undigested 223 bp product indicative of
A
ACCTTGGAAG AGGAGCAACT ACTGCTGGTG GTGACAAGCA CATTT000AA TGGAGACTGT
TC C
--C C
B
TTCAGGTACG CTGTGTTTGG CCTTGGCTCC AGCATGTACC CTCAGTTCTG
T
T- ---0
T- ---0
TLEEEQLJIJLJV\TTSTFGNODCPSNGQTLKKSLFMLNELNHTFRYAVFGLOS SMYPQFCA
R
V MK--G
P MR - -G
C----R 0--ER K---NR 1k---
C----R 0--ER K---NR 1k---
S4'I Acil
0 ct'4 4'
220
201
154
134
75—
223
A
223 bp
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r-macNOS, but also the 154 bp fragment characteristic of r-
vsmNOS. The 108 bp r-hepNOS digestion product was not
observed. As seen in Table 1, the two isoforms appeared to be
comparably abundant in the cortex, whereas r-macNOS tran-
scripts appeared to be roughly 1.5- to 2-fold more abundant than
r-vsmNOS in the outer and inner medulla of the uninduced rat
kidney using this methodology. These data suggest that the two
iNOS mRNAs are differentially expressed in the renal zones of
the normal rat.
Relative quantitation of iNOS mRNAs in microdissected structures
of the normal kidney
To determine the microlocalization of iNOS transcripts along
the nephron, we microdissected glomeruli, PCTs, PSTs, mTALs,
CCDs, IMCDs, and arcuate and interlobular arteries, isolated
their RNA, and performed RT-PCR with the iNOS primers. As
illustrated in Figures 4A and 4D, iNOS cDNAs were amplified
from each of these structures. To determine which of the iNOS
cDNAs were represented in the amplified products, we subjected
the PCR products to restriction analysis with StyI and AciI as
described above. For the isolated glomeruli, restriction cleavage
patterns characteristic of both r-macNOS and r-vsmNOS were
detected in three of five experiments, whereas restriction frag-
Fig. 3. Restriction cleavage analysis of iNOS
PCR products from normal rat kidney. (A) Map
of Sty! and AciI cleavage sites for 1NOS isoform
cDNAs in the regions amplified by PCR. (B)
RT-PCR products obtained from each
parenchymal zone (Fig. 1) were digested with
StyI orAcil and analyzed on an ethidium
bromide-stained 2.5% agarose gel. Molecular
weight standards were the 1 kb ladder from
GIBCO-BRL. These results are representative
of four experiments.
Table 1. Comparison of relative abundance of iNOS mRNAs in rat
kidney
Ratio of vsmNOS/macNOS
Control
LPS-
treated
P
(vs. controls)
Cortex
Outer medulla
Inner medulla
1.3 0.6
0.5 0.2
0.7 0.4
19.2 8.4
7.6 2.7
30.7 13.5
=0.05
<0.02
<0.03
PCR was performed in the presence of [a-32PJdCTP on equivalent
amounts of cDNA prepared from the indicated zones of control and
LPS-treated rats. Equal aliquots of the resultant PCR products were
digested individually to completion with Sty! and AciI, and size-fraction-
ated on agarose gels (Figs. 2 and 8). The 139 bp Sty! band (indicative of
r-macNOS) and the 154 bp AciI band (characteristic of r-vsmNOS) were
excised from the gel, and their incorporated radioactivity was measured by
scintillation counting. After correction for minor differences in product
size, the ratio of the cpms of the two bands was calculated. The data
represent the mean SEM, N = 3 to 5. It should be emphasized that since
the efficiency of RT and of mRNA preservation (during the microdissec-
tion procedure) for these isoforms may differ, these data represent only a
crude approximation of their relative abundance.
ments characteristic of only r-macNOS were observed in the other
two experiments (the results of one of the latter experiments are
presented in Fig. 4B). In all of the glomerular samples, however,
Aq
$j C 6' 5' ,
220
201
154
134 —
220
201
154
134
220
201
154
134—
'0 223 bp
'0 223 bp
139bp
223 bp
$16' 6'
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Fig. 4. Detection and restriction cleavage analysis
of iNOS cDNAs amplified from microdissected
renal segments by RT-PCR. Primers iNOS1 and
iNOS2 were used in PCRs with cDNAs
synthesized from the indicated structures. The
PCR products were analyzed on ethidium
bromide-stained 2.5% agarose gels after (A) no
treatment, (B) treatment with Sty!, or (C)
treatment with AciI. (D) Restriction cleavage
mapping of RT-PCR products from arcuate and
interlobular arteries. The minor bands in C
migrating at 84 bp in the glomerular and IMCD
digestion products represent the competitive
templates that were coamplified in these
specific experiments, and do not represent
restriction cleavage products. Abbreviations are
in text. Molecular weight standards were the 1
kb ladder from GIBCO-BRL. These results are
typical of 3 to 5 independent observations.
the r-macNOS cleavage products predominated. For each tubule
segment, nearly all of the amplified 223bp DNA was cleaved by
Sty! to the 139 bp fragment characteristic of r-macNOS (Fig. 4B).
A faint 197 bp band, which could have represented either a partial
digestion of r-macNOS (cleavage at only the 5' StyI site) or
complete digestion of r-hepNOS or r-vsmNOS was observed in
some samples. However, treatment of the PCR products with Ad!
did not cleave any of the DNAs (Fig. 4C), indicating that
r-macNOS was the principal, if not the only PCR product
amplified from these isolated tubules under basal conditions. In
220
201
154
134
C,S
Fig. 4. Continued
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contrast, r-vsmNOS was the major iNOS species expressed in the
arcuate and interlobular arteries (Fig. 4D).
We then exploited competitive PCR to compare the approxi-
mate number of r-macNOS mRNA molecules expressed in gb-
meruli and tubule segments microdissected from normal rats.
Figure 5A displays an ethidium bromide-stained agarose gel of a
representative competitor titration experiment with cDNA pre-
pared from microdissected PCTs. In this experiment, calculation
from the regression equation (Fig. 5B) indicated that equimolar
amounts of iNOS cDNA and competitor template were achieved
when approximately 125 molecules of z.r-macNOS cDNA were
coamplified in the PCR. The r values for all linear regression lines
for the competitive PCRs were > 0.85. As seen in Figure 6, the
mTAL and IMCD expressed by far the greatest amount of iNOS
cDNA, whereas the fewest iNOS transcripts were detected in the
PST and glomeruli. Since restriction cleavage analysis of the iNOS
PCR products derived from the tubule segments indicated that
r-macNOS was the principal, if not the only, iNOS mRNA basally
expressed (Fig. 4 A-c), we assumed that the total number of iNOS
molecules reported in Figure 6 represented almost exclusively
r-macNOS cDNA. Quantitation of iNOS mRNA in the vascular
structures was not performed.
Differential induction of iNOS mRNAs by LPS and cytokines
Since LPS is known to increase iNOS mRNA levels in the whole
kidney [24], we analyzed the effects of this agent on iNOS gene
expression in the cortex, outer medulla, and inner medulla of the
rat kidney to determine if iNOS mRNAs are differentially induced
among the parenchymal zones. To determine whether a change in
iNOS mRNA abundance was 1NOS-specific, the yield of iNOS
PCR products was normalized to the amount of /3-actin eDNA, a
"housekeeping" gene, amplified from the tissue samples in par-
allel experiments. This method of relative quantitation has been
used by numerous investigators [14, 23, 25]. Parametric experi-
ments (data not shown) indicated that the cycle numbers selected
for amplification of these two genes were within the range for
exponential amplification of the respective cDNAs. Moreover, the
increment in PCR product yield for iNOS eDNA was linear over
—2
Competitor molecules
Fig. 5. Relative quantitation of iNOS cDNA in isolated mTALs by compet-
itive PCR. Representative experiment (N = 4) in which mTAL cDNA was
coamplified with vaiying amounts of r-macNOS competitor template.
(A) The wild-type and mutant PCR products were separated by electro-
phoresis through a 2.5% agarose gel containing ethidium bromide. Initial
wild-type cDNA corresponded to 0.016 mm tubule. Corresponding con-
centrations of initial mutant templates (molecules/tube) are indicated
above each lane. Target and competitor bands were quantitated by
counting the cpm in the excised bands (normalized for the size of the PCR
product). Molecular weight standards were the 1 kb ladder from GIBCO-
BRL. (B) Regression analysis of the ratio of the log target/template cpm
plotted as a function of the initial amount of competitor template. The
approximate amount of target eDNA was calculated to be the x-axis value
at which the log competitor/target was 0.0. For this experiment, the
estimate of iNOS eDNA abundance was 125 copies for the sample, or 7812
copies/mm tubule.
the range of 20 to 10,000 molecules (data not shown). Figure 7
displays the relative levels of iNOS mRNAs isolated from the
parenchymal zones of control rats to those of rats pre-treated with
LPS. The LPS-treated animals expressed roughly two- to fivefold
greater levels of iNOS PCR products in each zone compared to
controls.
The iNOS PCR products amplified from the parenchymal zones
of the LPS rats (Fig. 8A) were then digested with StyI and AciI,
and the cleavage products were analyzed on agarose gels. As seen
in Figure 8B, the principal StyI and AciI cleavage products were
197 bp and 154 bp, respectively, a pattern indicative of r-vsmNOS
mRNA expression. The proportion of r-vsmNOS relative to
r-macNOS transcripts was significantly greater in each of the renal
parenchymal zones of the LPS-treated animals (Table 1), indicat-
ing that LPS preferentially induced the renal expression of
r-vsmNOS mRNA. We elected not to quantitate tubule mRNA
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Fig. 6. Relative quantitation of iNOS eDNA along the rat nephron. Com-
petitive PCR was used to quantify the content of iNOS in the microdis-
sected structures as described in Methods and Figure 5. Abbreviations are
in the text. The numerical mean values arc presented above each bar, and
the number of independent observation are presented in parentheses. t0
<0.05 for mTAL vs. PCI', PST, CCD. Other comparisons among tubule
segments = NS.
levels in the LPS-treated rats, because interstitial cells (which
would likely remain adherent to the microdissected tubules
despite washing) express iNOS mRNA when immunoactivated
[26]. Sample contamination by even a few of these induced,
adherent cells would confound interpretation of the data.
To determine whether the two iNOS mRNAs might be coex-
pressed in a single cell type, and to look for further evidence of
differential induction of the isoforms, we studied the response of
cultured glomerular mesangial cells to treatment with TNFa and
IF-y, cytokines that markedly stimulate iNOS gene transcription
[15, 16]. Restriction cleavage analysis of RT-PCR products am-
plified from control mesangial cells indicated that r-macNOS and
r-vsmNOS were expressed at roughly comparable levels under
basal conditions (Fig. 9A). Treatment of the cells with TNFs and
IF-y for seven hours resulted in a 20-fold increase in the relative
level of total iNOS mRNA (Fig. 9B), which was comprised
exclusively of r-vsmNOS transcripts (Fig. 9A). These data pro-
vided further evidence for preferential induction of the r-vsmNOS
isoform by immunological stimuli.
Discussion
The present studies were designed to address four principal
objectives: (i) to establish whether multiple iNOS transcripts are
expressed in the rat kidney; (ii) to determine, under basal
conditions, the intrarenal distribution and relative abundance of
iNOS mRNAs in vivo; (iii) to examine renal iNOS gene expression
in response to immunological stimuli; and (iv) to compare in vivo
findings with observations from previous studies of cultured renal
cells. Restriction cleavage analysis and DNA sequencing of RT-
PCR products identified two structurally distinct iNOS mRNAs,
r-vsmNOS and r-macNOS, in the renal parenchyma of the normal
rat. Using PCR methods to estimate relative mRNA abundance,
we found that r-macNOS is the principal iNOS isoform expressed
in the renal parenchyma under basal conditions, and that it is
heterogeneously expressed along the nephron, with particularly
Fig. 7. Effects of LPS treatment in vivo on renal expression of iNOS
mRNAs. Histogram showing the relative amount of total iNOS mRNA
expressed in the indicated zones of control and LPS-treated rats. iNOS
PCR product yield was normalized to the level of PCR-amplified /3-actin
cDNA (Methods). *J3 C 0.01, #P = 0.05, versus controls.
high levels in the mTAL and IMCD of the normal rat. Basal
expression of r-vsmNOS transcripts was detected in glomeruli and
arcuate and interlobular arteries, but not in any of the tubule
segments examined. Our results further demonstrate that treat-
ment with LPS in vivo augments expression of iNOS mRNAs in all
three zones of the renal parenchyma, and preferentially induces
expression of r-vsmNOS compared to r-macNOS mRNA. We also
show that the two iNOS mRNAs are coexpressed in cultured
glomerular mesangial cells, and that their relative abundance is
differentially modulated by cytokines. These results provide the
first description of the intrarenal localization and levels of expres-
sion of iNOS mRNAs in vivo', and the first evidence for coex-
pression of multiple iNOS isoforms in a single cell type and in any
rat tissue.
Previous molecular cloning studies [6, 11] showed a 7% differ-
ence in the primary structures between m-macNOS and r-
vsmNOS. This was believed to reflect species variation. However,
our finding of near molecular identity between r-macNOS and the
corresponding region of m-macNOS and its clear discrimination
from r-vsmNOS, suggests that r-macNOS and m-macNOS are
products of genes homologous between rat and mouse, and that
r-macNOS and r-vsmNOS are distinct molecular forms of iNOS.
Similar structural variation has been reported for the two human
iNOS clones. These human cDNAs, which differ at only seven
amino acids, appear to represent functionally distinct alleles
'After submission of this manuscript for review, Morrissey et al (Kidney
mt 45:998—1005, 1994) reported RT-PCR detection of iNOS mRNA in
cortex, outer and inner medulla, and microdissected glomeruli, mTALs,
medullary collecting ducts, and vasa recta. The DNA sequences reported
for the glomerular and outer medullary PCR products obtained from
normal rats were most closely related to r-vsmNOS; however, the molec-
ular identities of the PCR products for the other structures were charac-
terized only by Southern blotting with a 32P-labeled, internal oligonucle-
otide. In close agreement with our results, LPS treatment resulted in a
tenfold increase in glomerular and inner medullary iNOS mRNA abun-
dance, and a two- to threefold increase in outer medullary iNOS mRNA.
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Fig. 8. Differential induction of renal iNOS
mRNAs by LPS. (A). Representative ethidium
bromide-stained agarose gel of PCR products
amplified from first strand cDNAs (RT+) or
RNAs (RT—) harvested from renal
parenchymal zones of an LPS-treated rat. NT
indicates PCR performed in the absence of any
template. (B) Restriction cleavage mapping of
PCR products from A. The principal cleavage
products were characteristic of r-vsmNOS.
Compare this pattern of restriction cleavage
fragments to those of an uninduced rat (Fig. 2
and Table 1). N = 5.
encoded by a common gene on chromosome 17 [27]. Heterolo-
gous expression of the cDNA encoding iNOS cloned from human
hepatocytes [9] resulted in iNOS activity that was partially depen-
dent on Ca2 and calmodulin, whereas comparable expression
and analysis of the iNOS cloned from human chondrocytes
revealed its activity to be independent of exogenous Ca2 and
calmodulin (10]. Similar functional differences were reported for
iNOS purified from rat macrophages [12] and hepatocytes [13].
Moreover, recent in vitro studies in rat aortic strips and cultured
vascular smooth muscle cells demonstrated different induction
mechanisms for iNOS in these two tissues [25]. LPS and IFN-y
induced iNOS mRNA expression in both tissue preparations, but
the mRNA expression in the cultured vascular smooth muscle
cells was potentiated by cycloheximide, whereas this inhibitor
attenuated the response in aortic strips. The authors concluded
from these data that different cellular signaling pathways for the
induction of iNOS mRNA existed in the two tissues. However,
since the molecular identity (or identities) of the INOS RT-PCR
product was not verified, these data [25] could also reflect
different induction mechanisms of distinct iNOS isoforms (which,
as in our study, would likely have been coamplified in the PCR
and indistinguishable on gels in their study) expressed in the two
tissues.
In our study, the high degree of structural homology between
r-macNOS and r-vsmNOS could represent transcription of one or
more pseudogenes, of separate, related genes, or of different
alleles of a common gene. The high level of r-macNOS transcripts
in the uninduced mTAL (a segment in which r-vsmNOS mRNA is
not detectable) coupled with evidence for iNOS immunoreactivity
in this segment under physiologic conditions [17], makes it very
unlikely that the r-macNOS RT-PCR products we observed
represent merely illegitimate or pseudogene transcripts. For
comparison to other competitive PCR data, the basal amount of
r-macNOS mRNA expressed in the mTAL, roughly 10,000 mol-
ecules of r-macNOS cDNAJmm tubule, is about three times
greater than the levels of 31-adrenergic receptor mRNA reported
for the cortical TAL [28]. Moreover, the fact that only r-macNOS
mRNA is identified in the uninduced CCD, together with recent
evidence that this segment possesses iNOS immunoreactivity and
functional iNOS activity under basal conditions [18], suggests that
r-macNOS mRNA is translated into functional protein. The
striking increase in r-vsmNOS mRNA in the renal zones of the
LPS-treated rat suggests that this isoform is primarily responsible
for renal NO production in endotoxemia. Thus, its expression,
too, is unlikely to reflect simply transcription of a pseudogene.
The fact that the two isoforms appear to be differentially
expressed among the cell types of the kidney and differentially
respond to a common stimuli supports the likelihood that these
mRNAs are encoded by different iNOS genes or alleles, each
bearing distinct regulatory controls. If r-macNOS and r-vsmNOS
are encoded by nonallelic genes, this occurrence would be anal-
ogous to the CMF1a [29] and CMF1b [30] isoforms of the closely
NOS
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Fig. 9. Coexpression and differential
induction of iNOS mRNAs in cultured
glomerular mesangial cells. (A) Agarose
gel of undigested and restriction
endonuclease-digested PCR products from
control (lanes 1 to 4, 10) and TNFs and
IF-y-treated (lanes 5 to 9, 11) mesangial
cells. Lanes: 1, 5-undigested; 2, 6-StyI
digest; 3, 7-AciI digest; 4, 8-PCR of RNA
directly; 9-PCR in the absence of
template; 10, 11-PCR with 3-actin primers.
(B) Bar graph depicting relative
abundance of total iNOS mRNA (lanes I
and 5 of A) in control and cytokinc-
stimulated mesangial cells as measured by
PCR. iNOS PCR product yield
determined by competitive PCR was
normalized to the cpm incorporated into
PCR-amplified J3-actin eDNA (lanes 10
and 11 of A). N = 3.
related cytochrome P450 gene family: these isoforms share 96%
sequence identity but are encoded by separate genes. If r-
macNOS and r-vsmNOS are encoded by different alleles of a
homologous iNOS gene, then all of the rats we studied were
heterozygous at this locus, since we detected both r-macNOS and
r-vsmNOS in all the rats we studied. Our current efforts to clone
and express the full-length eDNA for r-macNOS, and to develop
DNA probes specific for r-macNOS and r-vsmNOS with which to
analyze genomic Southern blots, should allow us to determine
whether iNOS comprises a multigene family that encodes func-
tionally distinct iNOS isoenzymes in this species.
Since glomerular mesangial cells in culture synthesize NO and
increase cOMP levels in response to LPS and cytokines [15, 16],
our detection of r-macNOS and r-vsmNOS transcripts in the
uninduced, microdissected glomerulus and in cultured glomerular
mesangial cells presumably reflects low level expression of these
mRNAs in this cell type, There have been relatively few studies
using quantitative PCR of microdissected renal structures for
comparison with our data for iNOS. However the amount of
r-macNOS eDNA detected in the uninduced, microdissected
glomeruli is only about one-tenth the amount of tissue inhibitor of
metalloproteinases-1 cDNAs detected in human glomeruli sub-
jected to a similar preparation and analysis [31]. The absence of
iNOS immunolabeling in the mesangium of normal rats [17]
further indicates that iNOS expression in these cells under basal
conditions is low. Since iNOS activity has also been attributed to
endothelial cells, and an iNOS antibody immunolocalized to the
myoepithelial cells in the wall of the rat afferent arteriole [171, it
is also possible that glomerular endothelial cells or afferent
arterioles express one or more of the iNOS mRNAs. Further
studies to determine which iNOS genes are expressed in the renal
preglomerular resistance vessels are clearly warranted.
Among the renal tubule segments, r-macNOS was detected
most abundantly in the mTAL and the IMCD, with lesser
amounts in the PCT and CCD, and the least amount in the PST.
Preliminary studies in a cultured mTAL cell line indicate that
these cells express macNOS mRNA and produce NO under basal
conditions, and that these levels are dramatically augmented in
response to cytokines (M. Mohaupt and B. Kone, unpublished
observations). The CCD is comprised of multiple cell types,
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whereas the mTAL cell population is believed to be morpholog-
ically and functionally homogeneous. The fact that r-macNOS
transcript abundance/mm tubule in the CCD was much less than
in the mTAL presumably reflects the fact that r-macNOS is
primarily expressed in the intercalated cells of the CCD [181,
whereas it would be expected to be expressed in all cells of the
mTAL. Moreover, the abundance of r-macNOS mRNA in the
mTAL and IMCD under basal conditions likely contributes to the
high levels of NO production and NO-dependent cGMP genera-
tion in the renal medulla [32]. Finally, our detection of r-macNOS
mRNA in the proximal tubule segments and IMCDs in vivo
substantiates the findings of macNOS gene expression NO pro-
duction in these cell types in tissue culture [14]. Of the microdis-
sected structures analyzed in this report, we detected basal
expression of r-vsmNOS only in glomeruli and vasculature. The
fact that r-vsmNOS transcript abundance appeared to be compar-
atively greater in the cortex than in the other parenchymal zones
(Table 1), presumably reflects its expression in the glomeruli and
vasculature or in other cortical nephron segments not examined in
this report. It remains to be determined whether other, non-
vascular renal cells tonically express r-vsmNOS. Given the pref-
erential induction of r-vsmNOS in the kidney after LPS treatment,
identification of the cells in which this isoform is expressed under
immunoactivated conditions will also be important. Clearly "mac-
NOS" and "vsmNOS" are convenient descriptive terms and do
not precisely describe the cellular localization of these mRNAs.
The specific roles that iNOS gene expression plays in modulat-
ing renal hemodynamic or tubule transport functions under
physiologic or pathophysiologic conditions remain to be estab-
lished. NO is known to activate guanylate cyclase and thereby
increase production of cGMP [1]. Recent studies have shown that
the CCD (the only nephron segment examined) expresses mRNA
encoding the cd/132 heterodimer of the guanylyl cyclase-linked
NO receptor [331, and that NO synthesized by iNOS modulates
H-ATPase activity in the CCD under physiologic conditions [181.
Other data indicate that both luminal and intracellular cGMP
inhibit net chloride reabsorption in the mTAL [34, 35]. Moreover,
sodium nitroprusside, which is metabolized into NO, mimics the
inhibitory effect of 8BrcGMP on ion transport in this segment
[351. Thus the high transcript levels of r-macNOS in the mTAL
may reflect a role of NO, acting in an autocrine or paracnne
fashion, in modulating the basal reabsorptive function of this
epithelium, or of neighboring tubules (S3 segment of the proximal
tubule). It is also possible that constitutive NO production by
r-macNOS in the mTAL plays a role in maintaining and regulating
medullary blood flow and oxygenation [36].
Our results indicate that endotoxemia markedly increases iNOS
mRNAs throughout the rat kidney, with dramatic increases in the
proportion of r-vsmNOS transcript levels. Given the vasodilator,
cytostatic and cytotoxic properties of NO, the pathophysiological
consequences of this high level iNOS expression are likely to be
multifaceted. Although iNOS expression in solid organs has been
postulated to be cytoprotective, through its prevention of micro-
thrombosis and oxygen radical-mediated injury [2, 7], NO in high
concentrations has also been shown to be toxic to the same cells
that produce it as well as to neighboring cells [1, 2]. Thus it
remains plausible that, in addition to hypotensive/ischemic injury,
direct toxic effects of this high level NO production could con-
tribute to the acute tubular injury accompanying septicemia and
septic shock. Support for this hypothesis comes from the obser-
vation that endotoxemia differentially exacerbates ischemic tubu-
lar injury in the renal medulla of the rat [37]. Further studies will
be needed to determine whether enhanced iNOS expression
contributes to the genesis or the prevention of renal injury in
septicemia. In a similar manner, enhanced expression of iNOS
mRNA in mesangial cells may contribute to immune-mediated
glomerular injury [38}.
Several potential limitations of our competitive PCR and
microdissection method should be born in mind. First, since we
used competitor DNA, rather than cRNA fragments for quanti-
tation, we did not directly control for differences in the efficiency
of RNA isolation, RNA preservation (during the tissue harvest-
ing), or the efficiency of RT. Differences in the efficiency of RT of
the two iNOS mRNAs or in their susceptibility to degradation,
may have distorted our results. Thus our data provide only an
estimate of the relative number of copies of iNOS mRNA
expressed among the different nephron segments. Nonetheless,
since our principal goal was to determine the relative, rather than
the absolute, amounts of iNOS mRNAs along the nephron, we
believe our results to be informative. The second limitation relates
to the fact that microdissected renal structures are always, even
with the best dissection and washing techniques, contaminated by
other adherent cells. Given the sensitivity of the RT-PCR method,
we may have detected iNOS mRNA expression in these adherent
cells as well. However, given the relative abundance of iNOS
transcripts we observed in the different structures and the corre-
lation (in the case of the mTAL and CCD) of transcript abun-
dance (this study) with iNOS immunoreactivity [17, 18], it is
unlikely that sample contamination contributed to the measured
mRNA values sufficiently to skew the data and alter our interpre-
tations. Finally, since translational and post-translational mecha-
nisms may potentially regulate the abundance and activity of the
iNOS isoenzymes, our measurements of iNOS mRNA abundance
may not directly correlate with iNOS activity and NO production.
Until sufficient sequence information, particularly of the 5' and
3' untranslated regions, is available for r-macNOS to guide the
design of hybridization probes specific for the different iNOS
isoforms, analyses of iNOS mRNA abundance and distribution by
RNA blot and in situ hybridization studies will remain problem-
atic. Hybridization studies using m-macNOS, r-hepNOS, or r-
vsmNOS cDNA probes must be interpreted with caution, since,
given the available sequence data, these methods cannot distin-
guish among the different isoforms. A case in point is the study of
Wood et al [8], in which an r-hepNOS cDNA was used to probe
Northern blots of mRNA harvested from induced hepatocytes
and RAW264.7 cells, a murine rnacrophage-derived cell line.
They observed a 4.5 kB transcript for both tissues, and concluded
that identical iNOS mRNAs were expressed in both tissues, and
that r-hepNOS was the sole rat homologue of murine macNOS.
Given our demonstration of two highly homologous iNOS
mRNAs in rat, such conclusions must be reinterpreted. Our
experience also demonstrates that the identity of the products for
each PCR reaction must be verified by restriction enzyme analysis
or DNA sequencing, since multiple iNOS isoforms may be
coamplified with the same set of primers, yielding products of
identical size. Given our evidence for differential induction of the
two isoforms by LPS and cytokines, this analysis is particularly
important in comparing iNOS gene expression in basal and
immunoactivated conditions. For example, in the study by Marke-
witz, Michael and Kohan [14], the original PCR product was
664 Mohauptet al: NO synthase mRNAs in kidney
sequenced and found to be identical to m-macNOS, but no
molecular identification of the PCR products was reported for the
subsequent cytokine-induction experiments. Thus it is unknown
whether the dramatic induction in iNOS mRNA and NO produc-
tion by the cytokine-stimulated IMCD cells was related to r-
macNOS or r-vsmNOS expression. Furthermore, the use of an
independent, internal oligonucleotide to probe Southern blots of
the PCR products, commonly employed to verify the molecular
identities of amplified DNAs', may not reliably discriminate
among these highly homologous iNOS isoforms.
In conclusion, this study offers the first evidence for the
expression of two structurally distinct iNOS mRNAs in the
normal, uninduced rat kidney, and for the distribution and
relative abundance of iNOS transcripts in glomeruli and specific
tubule segments in vivo, Our data indicate a wide distribution and
heterogeneous level of expression of r-macNOS mRNAs along
the nephron, and suggest that r-macNOS and r-vsmNOS are
distinct isoforms, subject to unique regulatory controls. Our
detection of r-macNOS transcripts in the mTAL and the CCD of
the uninduced rat provides the molecular correlate for the recent
findings of iNOS immunoreactivity in these segments under basal
conditions. Our results also suggest that transcription of the iNOS
gene(s) in the normal kidney does not depend solely on prior
administration of LPS or cytokines, and they raise the possibility
that basal NO production by iNOS may play a greater role in
normal renal physiology than heretofore appreciated. Given the
fact that constitutive "neuronal" NOS is also expressed in several
of these nephron segments [39], our results suggest the potential
for multiple control points governing the intrarenal regulation of
NO production.
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